上海交通大学学报（医学版）

上海交通大学学报（医学版） >

2021 , Vol. 41 >Issue 8: 999 - 1008

DOI: https://doi.org/10.3969/j.issn.1674-8115.2021.08.002

论著 · 基础研究

结合珠蛋白通过抑制ERK1/2减轻肝细胞铁死亡

  • 魏倩 ,
  • 张颖婷 ,
  • 林龙帅 ,
  • 何恩俊 ,
  • 何咏元 ,
  • 苏滢泓 ,
  • 段澄澄 ,
  • 王斯源 ,
  • 赵庆华 ,
  • 赵倩 ,
  • 贺明
展开
  • 1.上海交通大学医学院病理生理学系，细胞分化与凋亡教育部重点实验室，上海 200025
    2.上海交通大学附属第一人民医院骨科，上海 201620
    3.上海交通大学应激与肿瘤创新单元（2019RU043），中国医学科学院，上海 200025
魏倩（1998—），女，硕士生；电子信箱：1102225683@qq.com。
贺明，电子信箱：heming@shsmu.edu.cn。

网络出版日期: 2021-08-13

基金资助

国家自然科学基金(82070603);上海市自然科学基金(19ZR1428400);上海交通大学医学院高水平地方高校创新团队(SSMU-ZDCX20180800);中央高校基本科研业务费专项资金资助，中国医学科学院医学与健康科技创新工程(2019-I2M-5-051);国家重点研发计划(2020YFA0803403);上海交通大学医学院青年科技创新工作室资助项目(JYKCGZS15)

收起

Haptoglobin suppresses hepatocyte ferroptosis via inhibition of the ERK1/2 signaling pathway

  • Qian WEI ,
  • Ying-ting ZHANG ,
  • Long-shuai LIN ,
  • En-jun HE ,
  • Yong-yuan HE ,
  • Ying-hong SU ,
  • Cheng-cheng DUAN ,
  • Si-yuan WANG ,
  • Qing-hua ZHAO ,
  • Qian ZHAO ,
  • Ming HE
Expand
  • 1.Department of Pathophysiology, Key Laboratory for Cell Differentiation and Apoptosis Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
    2.Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 201620, China
    3.Shanghai Jiao Tong University, Research Units of Stress and Tumor (2019RU043), Chinese Academy of Medical Sciences, Shanghai 200025, China
HE Ming, E-mail: heming@shsmu.edu.cn.

Online published: 2021-08-13

Fold

摘要

目的·探究结合珠蛋白（haptoglobin，Hp）在肝细胞铁死亡（ferroptosis）中的作用及机制。方法·给予8周龄的C57BL/6J雄性小鼠正常饲料（normal iron diet，NID组，n=5）和高铁饲料（high iron diet，HID组，n=8）饲喂12周后，收集2组小鼠的肝脏和血清。利用血清学生化指标、肝脏苏木精-伊红（hematoxylin-eosin，H-E）染色、天狼星红染色、普鲁士蓝染色和4-羟基壬烯醛（4-hydroxynonenal，4-HNE）染色明确2组小鼠肝脏损伤、病理学改变、纤维化、铁沉积和脂质过氧化反应程度；利用RNA测序（RNA-sequencing，RNA-seq）技术和生物信息学分析高铁饮食对小鼠肝脏转录组表达的调控，并筛选新的调控铁死亡的候选基因。在AML-12小鼠肝细胞中过表达Hp或利用siRNA敲减Hp后，给予铁死亡诱导剂RAS合成致死分子3 （RAS-selective lethal small molecule 3，RSL3）和/或细胞外信号调节激酶1/2 （extracellular regulated protein kinases 1/2，ERK1/2）活性抑制剂SCH772984，利用细胞计数、real-time PCR和C11-BODIPY581/591免疫荧光及流式细胞术等实验明确Hp在肝细胞铁死亡中的作用及机制。结果·相较于NID组小鼠，HID组小鼠血清中谷丙转氨酶（glutamic-pyruvic transaminase，GPT）和谷草转氨酶（glutamic-oxalacetic transaminase，GOT）水平明显升高，肝脏出现明显的肝细胞死亡、纤维化、铁沉积和脂质过氧化产物累积。RNA-seq及生物信息学分析结果分析发现，HID组小鼠肝脏中急性期反应、氧化还原反应、催化反应及血红蛋白结合等信号通路发生了明显的变化，而Hp mRNA在HID组显著下调。而且，HID组小鼠肝组织及RSL3处理的AML-12肝细胞中的Hp mRNA和蛋白表达水平均明显降低。重要的是，在AML-12肝细胞中，Hp过表达可明显减轻RSL3引起的肝细胞脂质过氧化和铁死亡。反之，Hp敲减可加重RSL3引起的肝细胞铁死亡。机制上，Hp明显抑制RSL3引起的肝细胞ERK1/2磷酸化的增强；而且，SCH772984可明显恢复Hp敲减导致的肝细胞脂质过氧化和铁死亡的加重。结论·Hp是一种新的肝细胞铁死亡抑制分子，而且Hp主要通过抑制ERK1/2活性减轻肝细胞铁死亡及其引起的肝损伤。

关键词： 结合珠蛋白; 肝细胞; 铁死亡; 脂质过氧化; 细胞外信号调节激酶1/2

本文引用格式

魏倩 , 张颖婷 , 林龙帅 , 何恩俊 , 何咏元 , 苏滢泓 , 段澄澄 , 王斯源 , 赵庆华 , 赵倩 , 贺明 . 结合珠蛋白通过抑制ERK1/2减轻肝细胞铁死亡[J]. 上海交通大学学报（医学版）, 2021 , 41(8) : 999 -1008 . DOI: 10.3969/j.issn.1674-8115.2021.08.002

Abstract

Objective

·To explore the role and mechanism of haptoglobin (Hp) in hepatocyte ferroptosis.

Methods

·Thirteen 8-week-old C57BL/6J male mice were randomly divided into two groups: one group of mice were fed with normal iron diet (NID group, n=5) and the other were fed with high iron diet (HID group, n=8). After 12 weeks, the murine serums and livers were collected from both groups. Liver injury, histopathological changes, hepatic fibrosis, iron deposition and peroxidation in murine liver tissues were determined by serum index test, hematoxylin-eosin (H-E) staining, Sirius red staining, Prussian blue staining and 4-hydroxynonenal (4-HNE) staining, respectively. RNA-sequencing (RNA-seq) and bioinformatics were used to analyze the effect of high iron diet on the expression of transcriptome in the murine livers and to screen new candidate genes that might regulate ferroptosis. After Hp was overexpressed or knocked down in mouse liver cells (AML-12), RAS-selective lethal small molecule 3 (RSL3) or/and extracellular regulated protein kinases 1/2 (ERK1/2) inhibitor SCH772984 was/were added to cells. The role and mechanism of Hp in hepatocyte ferroptosis were determined by cell counting, real-time PCR, C11-BODIPY581/591 immunofluorescence and flow cytometry.

Results

·After 12 weeks of feeding, the levels of glutamic-pyruvic transaminase (GPT) and glutamic-oxalacetic transaminase (GOT) in the HID group significantly increased compared with the NID group. The high iron diet induced hepatocytes death, hepatic fibrosis, iron deposition and lipid peroxidation products accumulation. RNA-seq analysis and bioinformatics results showed that acute phase response, catalytic activity response, antioxidant activity and hemoglobin binding signaling pathways were significantly regulated in the livers of HID mice, and Hp mRNA decreased significantly. Furthermore, the mRNA and protein expression levels of Hp in liver tissues of HID mice and in AML-12 hepatocytes treated with RSL3 obviously decreased. Importantly, Hp significantly alleviated lipid peroxidation and ferroptosis induced by RSL3 in AML-12 hepatocytes. Meanwhile, Hp suppressed RSL3-induced phosphorylation of ERK1/2 in AML-12 hepatocytes. Moreover, ERK1/2 inhibitor SCH772984 totally reversed the aggravation of hepatocyte ferroptosis induced by Hp knockdown.

Conclusion

·Hp is a novel inhibitory molecule in hepatocytes ferroptosis, which alleviates hepatocyte ferroptosis and liver injury by inhibiting ERK1/2 signaling pathway.

Key words： haptoglobin (Hp); hepatocyte; ferroptosis; lipid peroxidation; extracellular regulated protein kinases1/2 (ERK1/2)

参考文献

1 Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications[J]. Cell Res, 2021, 31(2): 107-125.
2 Liu J, Song X, Kuang F, et al. NUPR1 is a critical repressor of ferroptosis[J]. Nat Commun, 2021, 12(1): 647.
3 Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1-2): 317-331.
4 Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072.
5 Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis[J]. Nat Chem Biol, 2017, 13(1): 81-90.
6 Yuan H, Li X, Zhang X, et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis[J]. Biochem Biophys Res Commun, 2016, 478(3): 1338-1343.
7 Macías-Rodríguez RU, Inzaugarat ME, Ruiz-Margáin A, et al. Reclassifying hepatic cell death during liver damage: ferroptosis-A novel form of non-apoptotic cell death?[J]. Int J Mol Sci, 2020, 21(5): 1651.
8 Gao W, Zhao J, Gao Z, et al. Synergistic interaction of light alcohol administration in the presence of mild iron overload in a mouse model of liver injury: involvement of triosephosphate isomerase nitration and inactivation[J]. PLoS One, 2017, 12(1): e0170350.
9 Liu CY, Wang M, Yu HM, et al. Ferroptosis is involved in alcohol-induced cell death in vivo and in vitro[J]. Biosci Biotechnol Biochem, 2020, 84(8): 1621-1628.
10 Tsurusaki S, Tsuchiya Y, Koumura T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis[J]. Cell Death Dis, 2019, 10(6): 449.
11 贺明, 魏倩, 张颖婷. 铁死亡相关机制与其在肝脏相关疾病中作用的研究进展[J]. 上海交通大学学报(医学版), 2020, 40(11): 1519-1523.
12 Wang H, An P, Xie E, et al. Characterization of ferroptosis in murine models of hemochromatosis[J]. Hepatology, 2017, 66(2): 449-465.
13 Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy[J]. Proc Natl Acad Sci USA, 2019, 116(7): 2672-2680.
14 Wu C, Zhao W, Yu J, et al. Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells[J]. Sci Rep, 2018, 8(1): 574.
15 Li G, Yang J, Zhao G, et al. Dysregulation of ferroptosis may involve in the development of non-small-cell lung cancer in Xuanwei area[J]. J Cell Mol Med, 2021, 25(6): 2872-2884.
16 di Masi A, De Simone G, Ciaccio C, et al. Haptoglobin: from hemoglobin scavenging to human health[J]. Mol Aspects Med, 2020, 73: 100851.
17 Shu H, Zhang S, Kang X, et al. Protein expression and fucosylated glycans of the serum haptoglobin-β subunit in hepatitis B virus-based liver diseases[J]. Acta Biochim Biophys Sin (Shanghai), 2011, 43(7): 528-534.
18 Outten FW, Theil EC. Iron-based redox switches in biology[J]. Antioxid Redox Signal, 2009, 11(5): 1029-1046.
19 Wang Y, Liu Y, Liu J, et al. NEDD4L-mediated LTF protein degradation limits ferroptosis[J]. Biochem Biophys Res Commun, 2020, 531(4): 581-587.
20 Yuan H, Li X, Zhang X, et al. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation[J]. Biochem Biophys Res Commun, 2016, 478(2): 838-844.
21 Alvarez SW, Sviderskiy VO, Terzi EM, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis[J]. Nature, 2017, 551(7682): 639-643.
22 Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process[J]. Cell Res, 2016, 26(9): 1021-1032.
23 Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol, 2017, 13(1): 91-98.
24 Lei G, Zhang Y, Koppula P, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression[J]. Cell Res, 2020, 30(2): 146-162.
25 Yu Y, Jiang L, Wang H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis[J]. Blood, 2020, 136(6): 726-739.
26 Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer[J]. J Hematol Oncol, 2019, 12(1): 34.
27 Gnanapradeepan K, Basu S, Barnoud T, et al. The p53 tumor suppressor in the control of metabolism and ferroptosis[J]. Front Endocrinol (Lausanne), 2018, 9: 124.
28 Qiu Y, Cao Y, Cao W, et al. The application of ferroptosis in diseases[J]. Pharmacol Res, 2020, 159: 104919.
29 Sreekanth GP, Chuncharunee A, Sirimontaporn A, et al. Role of ERK1/2 signaling in dengue virus-induced liver injury[J]. Virus Res, 2014, 188: 15-26.
30 Long T, Wang L, Yang Y, et al. Protective effects of trans-2,3,5,4'-tetrahydroxystilbene 2-O-β-D-glucopyranoside on liver fibrosis and renal injury induced by CCl4via down-regulating p-ERK1/2 and p-Smad1/2[J]. Food Funct, 2019, 10(8): 5115-5123.
31 Sampey BP, Stewart BJ, Petersen DR. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal[J]. J Biol Chem, 2007, 282(3): 1925-1937.
32 Thakur V, Pritchard MT, McMullen MR, et al. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-α production[J]. J Leukoc Biol, 2006, 79(6): 1348-1356.
33 Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation[J]. J Hepatol, 2009, 50(6): 1258-1266.
34 Wang Z, Yao T, Song Z. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease[J]. J Lipid Res, 2010, 51(11): 3158-3165.
35 Dong J, Viswanathan S, Adami E, et al. Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH[J]. Nat Commun, 2021, 12(1): 66.
Options
文章导航

/

〈 〉